Recent Updates
Recently added Catalysts
CTMX Positive Sentiment

CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025

Monday, May 5, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: CytomX Therapeutics, Inc. will report its first quarter financial results on May 12, 2025, before the U.S. markets open. A conference call and webcast will follow the announcement, allowing stakeholders to engage directly with the company's leadership. The live webcast can be accessed through CytomX's website, with an archived replay available afterward. This event is part of the company's ongoing commitment to financial transparency and investor communication.
Price reaction · baseline $0.802 (2025-05-02 close) · clean, no other CTMX news in the window
day 0 close
+19.9%
day 1
+20.5%
day 3 · peak
+35.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • CytomX Therapeutics is preparing to report its financial results, indicating ongoing business activity.
  • The planned conference call reflects transparency and engagement with investors.
  • The scheduled reporting of Q1 results suggests potential positive financial performance.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+53%
120-day peak, hindsight
Typical move
6.8%
average across 7 past catalysts
Cash runway
~54 mo
Minimal dilution risk
Lead asset
CX-2009
Phase 2 · Neoplasms

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report first quarter financial results on Monday, May 12, 2025, before the open of the U.S. markets. Following the announcement, the Company will host a conference call and webcast at 8:00 a.m. ET / 5:00 a.m. PT.
Participants may access the live webcast of the conference call from the Events and Presentations page of CytomX’s website at https://ir.cytomx.com/events-and-presentations. Participants may register for the conference call here and are advised to do so at least 10 minutes prior to joining the call. An archived replay of the webcast will be available on the Company’s website.
About CytomX Therapeutics, Inc.
SVP, Chief Financial Officer
Precision AQ (formerly Stern Investor Relations)

Frequently Asked Questions

When will CytomX report its Q1 financial results?

CytomX will report Q1 financial results on May 12, 2025.

What time is the CytomX conference call?

The conference call is scheduled for 8:00 a.m. ET / 5:00 a.m. PT.

How can I access the live webcast?

The live webcast can be accessed on CytomX’s Events and Presentations page.

When will the archived webcast be available?

An archived replay of the webcast will be available on CytomX’s website.

ShareAdd on Google
Tags: CTMX Viatris Investor Conferences Healthcare CytomX Therapeutics financial results conference call biologics
Last updated: May 5, 2025

Biotech snapshot

Cash runway
$330M liquidity · $6M/mo burn
~54 mo
Minimal dilution risk
Lead asset
CX-2009Phase 2
Neoplasms →

Catalyst track record

+53%
best trade around CTMX's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for CTMX.

See every catalyst's timing & PoA →